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A B S T R A C T
Background
Diet as one aspect of lifestyle is thought to be one of themodifiable risk factors for the development of type 2 diabetes mellitus (T2DM).
Information is needed as to which components of the diet could be protective for this disease.
Objectives
To asses the effects of whole-grain foods for the prevention of T2DM.
Search methods
We searched CENTRAL, MEDLINE, EMBASE, CINAHL and AMED.
Selection criteria
We selected cohort studies with a minimum duration of five years that assessed the association between intake of whole-grain foods or
cereal fibre and incidence of T2DM. Randomised controlled trials lasting at least six weeks were selected that assessed the effect of a
diet rich in whole-grain foods compared to a diet rich in refined grain foods on T2DM and its major risk factors.
Data collection and analysis
Two authors independently selected the studies, assessed study quality and extracted data. Data of studies were not pooled because of
methodological diversity.
Main results
One randomised controlled trial and eleven prospective cohort studies were identified. The randomised controlled trial, which was
of low methodological quality, reported the change in insulin sensitivity in 12 obese hyperinsulinemic participants after six-week
long interventions. Intake of whole grain foods resulted in a slight improvement of insulin sensitivity and no adverse effects. Patient
satisfaction, health related quality of life, total mortality and morbidity was not reported.
Four of the eleven cohort studies measured cereal fibre intake, three studies whole grain intake and two studies both. Two studies
measured the change in whole grain food intake and one of them also change in cereal fibre intake. The incidence of T2DM was
assessed in nine studies and changes in weight gain in two studies. The prospective studies consistently showed a reduced risk for high
intake of whole grain foods (27% to 30%) or cereal fibre (28% to 37%) on the development of T2DM.
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Authors’ conclusions
The evidence from only prospective cohort trials is considered to be too weak to be able to draw a definite conclusion about the
preventive effect of whole grain foods on the development of T2DM. Properly designed long-term randomised controlled trials are
needed. To facilitate this, further mechanistic research should focus on finding a set of relevant intermediate endpoints for T2DM and
on identifying genetic subgroups of the population at risk that are most susceptible to dietary intervention.
P L A I N L A N G U A G E S U M M A R Y
Whole grain foods for the prevention of type 2 diabetes mellitus
Food products derived from cereal grains as wheat, rice, corn, rye, oat, and barley constitute a major part of the daily diet in many
countries. In refined-grain products, the bran and germ of the grain, which contain the major amount of nutrients and dietary fibre,
have been removed and only the starchy inner part of the grain (ca. 80% of the whole grain) is used. Whole grain foods contain either
intact, flaked or broken grain kernels, coarsely ground kernels or flour that is made from whole grains (whole-meal flour). In this review
the effect of whole grain foods and cereal fibre (as a marker of whole-grain food intake) on the prevention of type 2 diabetes mellitus
(T2DM) was assessed using all available prospective cohort studies and randomised controlled trials. Only one randomised controlled
trial was found which was of low methodological quality. This study investigated in 12 overweight persons during six weeks the effect
of the consumption of refined grain foods versus that of whole grain foods on insulin sensitivity (risk factor for the development of
T2DM). Intake of whole grain foods resulted in a slight improvement of insulin sensitivity, increased bowel movements and no adverse
effects. No information was given about patient satisfaction, health related quality of life, total mortality and morbidity. In addition
eleven prospective cohort studies were found. One study was conducted in Finland and the rest in the United States of America of
which seven were done in health care workers. Some of the studies were of limited quality. They consistently showed that a high intake
of whole grain foods or cereal fibre is associated with a lower risk of the development of T2DM. However, evidence for a protective
effect coming from prospective cohort studies only has to be considered as weak as with this design no cause and effect relationship
can be established. Well-designed randomised controlled trials are needed to be able to draw definite conclusions about the preventive
effects of whole grain consumption on development of T2DM.
B A C K G R O U N D
Description of the condition
Diabetes mellitus is a metabolic disorder resulting from a defect
in insulin secretion, insulin action, or both. A consequence of this
is chronic hyperglycaemia (i.e. elevated levels of plasma glucose)
with disturbances of carbohydrate, fat and protein metabolism.
Long-term complications of diabetes mellitus include retinopa-
thy, nephropathy and neuropathy. The risk of cardiovascular dis-
ease is increased. For a detailed overview of diabetes mellitus,
please see under ’Additional information’ in the information on
the Metabolic and Endocrine Disorders Group in The Cochrane
Library (see ’About the Cochrane Collaboration’, ’Collaborative
review groups - CRGs’). For an explanation of methodological
terms, see the main glossary in The Cochrane Library.
Description of the intervention
Type 2 diabetes is the most prevalent form of diabetes worldwide
and develops as a consequence of two defects. In an early stage
target tissues are unable to respond to normal circulating concen-
trations of insulin (insulin resistance). As a consequence the out-
put of insulin from the pancreatic beta-cells is increased (hyper-
insulinemia) to maintain normal blood glucose levels. In a later
stage insulin secretion may decline as a result of beta-cell dysfunc-
tion. This leads to impaired glucose tolerance, impaired fasting
glycaemia (glucose values above the normal range but below those
defined as diagnostic of diabetes) or both which are associated with
an increased risk of type 2 diabetes (Unwin 2002; WHO 1999).
Excessive weight gain and central obesity are other well established
risk factors for the development of type 2 diabetes (FAO/WHO
2003). The incidence of obesity and type 2 diabetes are increasing
rapidly worldwide and pose enormous economic as well as social
costs to societies, urging for preventive measures. Although ge-
netic elements are involved in the pathogenesis of type 2 diabetes,
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the rapid changes in incidence rates suggest a particularly impor-
tant role for environmental factors. Besides physical activity, diet
is thought to play a key role as a modifiable risk factor. Charac-
teristics of a diet favouring the development of obesity and type 2
diabetes are currently defined as high in saturated fat and energy-
dense foods as well as low in fruit and vegetables (FAO/WHO
2003). The contribution of the type of starchy food - an important
component of the diet worldwide - however, has not been estab-
lished well. Starchy foods are derived mainly from cereal grains
which undergo a refining process or will be used entirely (whole
grain foods).
How the intervention might work
Food products derived from cereals as wheat, rice, corn, rye, oat,
and barley constitute a major part of the daily diet in many coun-
tries (FAO 1998). In refined-grain products, the bran and germ of
the grain which contain themajor amount of micronutrients, phy-
tochemicals and dietary fibre (non-digestible carbohydrates and
lignin), have been removed and only the starchy endosperm (ca.
80% of the whole grain) is used. Whole grain foods contain ei-
ther intact, flaked or broken grain kernels, coarsely ground ker-
nels or flour that is made from whole grains (whole-meal flour).
In epidemiological studies foods commonly are classified as whole
grain as they contain more than 25% by weight whole-grain or
bran (Jacobs 1998). The Food and Drug Administration (FDA
2005) has approved a health claim for whole-grain foods with a
whole-grain content of more than 51% by weight per reference
amount customarily consumed and more recently has announced
in a FDA guidance document (draft guidelines) that it “considers
’whole grain’ to include cereal grains that consist of the intact,
ground, cracked or flaked fruit of the grains whose principal com-
ponents -- the starchy endosperm, germ and bran -- are present
in the same relative proportions as they exist in the intact grain”
(FDA 2006).
Changes in food patterns such as a decrease of consumption of
whole grain foodswhich occurred simultaneouslywith the increase
of prevalence of chronic disease over the last decades have lead to
the hypothesis that constitutingwhole grain food by highly refined
grain foods is linked to the development of type 2 diabetes and
other chronic diseases (Burkitt 1975; Trowell 1975). There are
several hypotheses as to how whole grain foods might prevent type
2 diabetes. Beneficial effects on weight gain, for example, could be
explained by the larger volume and relatively low energy density of
whole grain food which is due to the presence of cereal fibre. This
promotes satiation and satiety thus leading to decreased energy
intake (Koh-Banerjee 2003). Consumption of whole grain foods
containing intact, broken or coarsely ground kernels or viscous
soluble fibre, results in a lower postprandial plasma glucose and
insulin response as compared to refined grain foods (Slavin 2003).
In view of the proposed aggravating effects of high postprandial
glucose and insulin concentrations on insulin sensitivity and beta-
cell failure, their suppression is considered to be beneficial (Ludwig
2002;Willett 2002). Also, the high content of antioxidants such as
vitaminE, phytic acid and seleniummight be advantageous (Slavin
2003) since there is emerging evidence that the pathogenesis of
diabetes is associated with increased oxidative stress (Dandona
2004; Robertson 2004; Sjoholm 2005).
From observational studies there is evidence for a protective effect
of whole-grain foods with regard to the development of type 2
diabetes (Fung 2002; McKeown 2002; Meyer 2000; Montonen
2003). More recently, higher intake of whole grains was also asso-
ciated with decreases in insulin resistance - a risk factor related to
the development of type 2 diabetes (Liese 2003; McKeown 2004;
Steffen 2003).
However, the protective effect of whole-grain foods on the de-
velopment of type 2 diabetes would ideally be evaluated by ran-
domised control trials because of their optimal control of con-
founding factors. To be able to observe differences in incidence
of type 2 diabetes the duration of the dietary intervention would
need to be very long. Alternatively, persons with at least one major
risk factors for type 2 diabetes could be chosen. Amelioration of
the risk factor could then be used as an indication of decreased risk
of development of type 2 diabetes. Still, it is likely that compli-
ance with the whole-grain diet decreases with time, especially in
persons who regard the diet as less palatable or might experience
adverse effects of the intervention. The relatively high content of
cereal fibre and resistant starch in the whole-grain diet might cause
increased bloating, flatulence or both in sensitive persons. Due to
these limitations with regard to trial duration and compliance ran-
domised controlled trials assessing the effect of whole-grain foods
on the development of type 2 diabetes are likely to be scarce.
Why it is important to do this review
Some reviews have been published addressing the relation be-
tween whole grain foods and the incidence of type 2 diabetes (Liu
2002; Murtaugh 2003). However, they were not systematically
performed with respect to literature search and did not include
quality assessment. Summarizing and evaluating the available ev-
idence -derived from prospective cohort studies and intervention
trials - concerning the possible protective effect of whole grain
foods could aid in identifying further research need and assist in
defining recommendations with regard to the intake of starchy
foods for the prevention of the development of type 2 diabetes.
O B J E C T I V E S
To asses the effects of whole-grain foods for the prevention of type
2 diabetes mellitus.
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M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials, controlled clinical trials and cohort
studies were considered.
Types of participants
Randomised controlled trials or controlled clinical trials
Inclusion criteria
Healthy persons and persons with at least one major risk factor for
type 2 diabetes were included. Major risk factors are overweight,
abdominal obesity, impaired glucose tolerance and insulin resis-
tance. We excluded children and adolescents less than 18 years
because of the well known differences in eating patterns.
Diagnostic criteria
Type 2 diabetes and impaired glucose tolerance: the diagnosis
should have been established using the standard criteria valid at
the time of the beginning of the trial (ADA 1997; ADA 1999;
NDDG 1979; Unwin 2002; WHO 1980; WHO 1985; WHO
1999).
Overweight
Body mass index greater than 25 (body mass in kg / height in (m
2)) (FAO/WHO 2003).
Abdominal obesity
Waist circumference equal to or more than 102 cm in men and
equal to or more than 88 cm in women (FAO/WHO 2003).
Insulin resistance
Cut-off values for defining insulin resistance vary since different
methods are used for assessment of insulin resistance (Monzillo
2003). Under hyperinsulinemic, euglycemic conditions, glucose
uptake below lowest quartile for background population under




Free living persons (older than 18 years of age) without previously
diagnosed diabetes mellitus.
Diagnostic criteria
Type 2 diabetes and impaired glucose tolerance: the diagnosis
should have been established using the standard criteria valid at
the time of the beginning of the trial (ADA 1997; ADA 1999;
NDDG 1979; Unwin 2002; WHO 1980; WHO 1985; WHO
1999).
Overweight
Body mass index greater than 25 (body mass in kg / height in (m
2)) (FAO/WHO 2003).
Abdominal obesity
Waist circumference equal to or more than 102 cm in men and
equal to or more than 88 cm in women (FAO/WHO 2003).
Insulin resistance
Cut-off values for defining insulin resistance vary since different
methods are used for assessment of insulin resistance (Monzillo
2003). Under hyperinsulinemic, euglycemic conditions, glucose
uptake below lowest quartile for background population under
investigation is defined as insulin resistance according to theWHO
(WHO 1999).
Types of interventions
Randomised controlled trials or controlled clinical trials
Trials were included which compared diets rich in whole-grain
foods (foods that contain more than 51% of whole grain) with
diets rich in refined-grain foods. Both diets should have similar
overall sugar, starch, fat and protein content.
Cohort studies
Studies had to assess the intake of whole-grain foods (foods that
contain more than 25% of whole grain) or cereal fibre (as marker
for whole grain food intake).
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Types of outcome measures
Primary outcomes
Randomised controlled trials or controlled clinical trials
Ideally incidence of type 2 diabetes is the main outcome.
However, it was anticipated that there are hardly any randomised
controlled trials or controlled clinical trials assessing the inci-
dence of type 2 diabetes because of the long intervention duration
needed.
Therefore, also trials assessing the changes in major risk factors
for type 2 diabetes, including impaired glucose tolerance, insulin
resistance and overweight were considered.
Cohort studies
• Incidence of type 2 diabetes mellitus.
Secondary outcomes
Randomised controlled trials or controlled clinical trials
• adverse effects (for example bloating, flatulence);
• patient satisfaction;






Timing of outcome assessment
Trials had to have a minimum of six weeks of intervention period.
Cohort studies
• Incidence of major risk factors for type 2 diabetes, including




• family history of diabetes;
• body mass index.
Timing of outcome assessment
Prospective studies had to have of a minimum duration of five
years.
Search methods for identification of studies
Electronic searches
The following electronic data bases were searched:
• The Cochrane Library (issue 2, 2006);
• MEDLINE (until May 2006);
• EMBASE (until May 2006);
• CINAHL (until May 2006);
• AMED (until May 2006).
The database of ongoing trials, ’Current Controlled Trials’
(www.controlled-trials.com - until May 2006) and the ’Science
Citation Index’ was searched (until October 2006), the latter to
identify relevant studies that cited the primarily retrieved studies.
No language restriction was applied for searching and study in-
clusion.
The described search strategy (see for a detailed search strategy
under Appendix 1) was used for MEDLINE. For use with the
other databases this strategy was slightly adapted.
Additional searches
Authors of relevant identified studies and other experts (authors of
reviews) were contacted in order to obtain additional references,
unpublished trials or ongoing trials.
Handsearches
The reference lists of all included studies and of review articles
were screened in order to identify possible studies of interest. The
handsearch of specialised journals was not done because the sen-
sitivity of the electronic data base search improved by omitting
study design limitations and all relevant journals were included in
the electronic data bases.
Data collection and analysis
Selection of studies
The title and abstract of each record of the search was indepen-
dently assessed by two authors (MGP, JJvB). Studies were rejected
if the article definitely did not meet the review’s inclusion criteria;
otherwise the full text of the study was obtained. Interrater agree-
ment for study selection was measured using the kappa statistic
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(Cohen 1960). Differences between authors’ results were resolved
by discussion.
Duplicate publications were aimed to be identified by comparing
publications of the same authors with respect to study populations,
location, date and follow-up time of the study.
Data extraction and management
From original reports of the studies data were independently ex-
tracted by two authors. Differences in results were resolved by dis-
cussion and if necessary a third author was consulted.
From (randomised) controlled trials the following data were ex-
tracted:
• general information: published/unpublished, title, authors,
source, country, year of publication, funding, duplicate
publication;
• trial characteristics: design, duration, randomizations,
concealment of allocation, blinding, checking of blinding;
• intervention: length of intervention, dietary advice/diet
provided, comparison interventions;
• participants: population, exclusion criteria, number (total,
per compared groups), age, gender, health condition, diagnostic
criteria used to define health condition, similarity groups at
baseline, medication used, assessment of compliance,
withdrawals/losses to follow-up, confounders: body mass index,
physical activity, family history of diabetes;
• outcomes: outcomes specified above, main outcomes
assessed in the study;
• results: for outcomes and times of assessment (including a
measure of variation), intention-to-treat analyses.
The following data were extracted from cohort studies (adapted
data extraction form of the Cochrane Non-Randomised Studies
Methods Group).
• general information: published/unpublished, title, authors,
source, country, year of publication, duplicate publication;
• study characteristics: design, dates of enrolment, follow-up;
• exposure: type, type of measurement, validation of
measurement, time-points measurements;
• outcome: type, criteria used, type of measurement,
validation of measurement;
• participants: number identified, number excluded, number
lost to follow-up, characteristics;
• results: total number cases, cases in group with lowest and
highest intake, results of outcome, confounders adjusted for.
Assessment of risk of bias in included studies
Randomised controlled trials or controlled clinical trials
The quality of reporting of each trial was assessed based largely on
the quality criteria specified by Schulz and by Jadad (Jadad 1996;
Schulz 1995). In particular, the following factors were studied:
(1) Minimisation of selection bias - a) was the randomisation pro-
cedure adequate? b) was the allocation concealment adequate?
(2) Minimisation of performance bias - were the participants and
people administering the treatment blind to the intervention?
(3) Minimisation of attrition bias - a) were withdrawals and drop-
outs completely described? was analysis by intention-to-treat?
(4) Minimisation of detection bias - were outcome assessors blind
to the intervention?
Ad2)As the treatmentwas a dietary intervention inwhich blinding
participants and people administering the food is not possible,
these criteria were not rated.
Based on these criteria, studies were broadly subdivided into the
following three categories (Higgins 2005):
A - all quality criteria met: low risk of bias.
B - one or more of the quality criteria only partly met: moderate
risk of bias.
C - one or more criteria not met: high risk of bias.
This classification was intended to be used as the basis of a sensi-
tivity analysis.
Cohort studies
The quality of cohort studies was assessed using the following
criteria (derived fromForm III for the assessment of a cohort study,
version February 2003, www.cochrane.nl):
- number of appropriate confounders investigated and adjusted
for;
- same method of measurement of outcome in exposed and unex-
posed group;
- quality of method used to assess outcome measures: self report
without validation, self report with validation, direct measure-
ment/medical records;
- quality of method used to assess whole-grain intake: food fre-
quency questionnaire without validation, food frequency ques-
tionnaire with validation; single measurement, repeated measure-
ment;
- duration and completeness of follow-up.
Quality of studies was independently examined by two authors.
Differences in results were resolved by discussion and if necessary
a third author was consulted.
Assessment of reporting biases
Publication bias was to be assessed by preparation of a ’funnel plot’
and examined statistically for signs of asymmetry (Egger 1997).
Data synthesis
Data were intended to be summarized statistically if they were
sufficiently similar, and of sufficient quality.
For continuous outcomes, weighted mean differences were to be
used to analyse the size of the effects of the interventions. The
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effect sizes for dichotomous data were to be expressed in terms of
relative risks, odds ratios or hazard ratios.
In RCTs intention-to-treat analysis was planned to be used when
the information was provided.
All data were to be initially analysed with a fixed-effect model.
Heterogeneity between trial results were to be tested by using a
standard chi-squared test. To quantify inconsistency the I-squared
statistic was to be used (Higgins 2003) which describes the per-
centage of the variability in effect estimates that is due to het-
erogeneity rather than sampling error. A value greater than 50%
was to be considered substantial heterogeneity. Possible causes of
heterogeneity were to be explored by conducting subgroup and
sensitivity analyses. If significant heterogeneity is found, it is un-
reasonable to assume that there is one ’true’ effect underlying the
data, that is constant across different populations and therefore a
random effects model was to be used.
Subgroup analysis and investigation of heterogeneity
When the amount of data permits, subgroup analyses were to be
conducted according to age, sex, duration of intervention, types of
whole grain foods and amounts of whole grain foods consumed,
since variations may be due to characteristics of dietary interven-
tion.
Sensitivity analysis
It was intended to perform sensitivity analyses in order to explore
the influence of the following factors on effect size:
• repeating the analysis excluding unpublished studies (if
there were any).
• repeating the analysis taking account of study quality, as
specified above.
• repeating the analysis excluding any very long or large
studies to establish how much they dominate the results.
• repeating the analysis excluding studies using the following
filters: diagnostic criteria, language of publication, source of
funding (industry versus other), country.
• repeating the analysis excluding studies about which no
primary consensus was reached.
The robustness of the results was also to be tested by repeating
the analysis using different measures of effect size (risk difference,
odds ratio etc.) and different statistical models (fixed and random-
effects models).
R E S U L T S
Description of studies
Results of the search
With the MEDLINE search 3395 possibly eligible studies were
found. With the search in EMBASE 1560 additional studies were
identified. The search in CINAHL added another 586 studies,
the search in AMED four and the search in The Cochrane Library
259 more studies (total 5804 possibly eligible studies). With the
initial screening of the 5804 possibly eligible studies 22 studies
were identified and the full text of these studies was obtained.
After detailed examination 11 studies were excluded. No further
study was found searching the database of ongoing trials (Current
Controlled Trials - www.controlled-trials.com) and scanning the
reference lists of all so far included studies and of review articles. By
searching the Science Citation Index to identify relevant studies
that have cited the primarily retrieved studies one further study
was found (van Dam 2006). For an overview of study selection
please see Figure 1 showing details of the amended QUOROM
(quality of reporting of meta-analyses) statement.
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Figure 1. QUOROM (quality of reporting of meta-analyses) flow chart of study selection
Authors of the identified relevant studies and other experts (au-
thors of reviews) were contacted in order to obtain additional ref-
erences, unpublished trials, or ongoing trials. No additional study
was retrieved by this means. The possibility that certain publica-
tions were duplicates was examined by comparing publications of
the same authors with respect to study populations, location, date
and follow-up time of the study. No duplicate publications were
identified.
Interrater agreement
The interrater agreement for study selection was measured using
the kappa statistic (Cohen 1960) and was 0.57 which indicates
moderate agreement. Differences between authors’ results were
resolved by discussion.
Missing data
Two authors were contacted to retrieve additional information.
Included studies
In total 12 studies were identified that met all the inclusion crite-
ria. One study was a randomised controlled trial and eleven were
cohort studies. Details of the randomised controlled trial are listed
in Appendix 2 and details of the prospective cohort studies are
shown in Appendix 3.
The following gives a brief overview:
Randomised controlled trial
Design and duration
The trial of Pereira et al (Pereira 2002) had a cross-over design
with two six-week feeding periods and a washout period of six to
nine weeks.
Participants
Twelve overweight or obese (BMI 27 to 36 kg/m2) hyperinsuline-
mic adults aged 25 to 56 years (six women, six men) took part in
the trial.
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Interventions
One diet contained products of refined grains, thus products with
no bran or germ and little fibre. In the other diet the refined grain
products where substituted by whole grain products. All food of
the two different diets was prepared at themetabolic kitchen of the
research centre where the study was conducted. The participants
stayed there during the two feeding periods and were asked to
consume all of the food provided to them and to consume no
other food, except energy-free beverages.
Outcome measures
Fasting insulin concentrations, insulin resistance (homeostasis
method) and insulin sensitivity (euglycemic hyperinsulinemic
clamp test) were determined.
Cohort studies
Design and duration
All 11 studies were prospective cohort studies. Four had a follow-
up duration of six years (Meyer 2000; Montonen 2003; Salmeron
1997a; Salmeron 1997b), three lasted eight years (Koh-Banerjee
2004; Schulze 2004; van Dam 2006), one nine years (Stevens
2002), one 10 years (Liu 2000) and two 12 years (Fung 2002;
Liu 2003). In all but one studies the results were reported in risks
across quintiles of whole-grain or cereal fibre intake. Montonen et
al. (Montonen 2003) assessed the risk across quartiles.
Participants
All participants were without previous diagnosis of diabetes. In
six studies participants were only women (Liu 2000; Liu 2003;
Meyer 2000; Salmeron 1997a; Schulze 2004; van Dam 2006).
In three studies only men participated (Fung 2002; Koh-Banerjee
2004; Salmeron 1997b), in the other two studies participants were
men and women. Age at base line of inclusion was 21 to 75 years,
and the age range of the cohorts varied from 14 to 47 years. One
study compared the risk of whites with that of African-Ameri-
cans (Stevens 2002). In one study participants were only African-
American women (van Dam 2006). In the other studies ethnic-
ity was not mentioned. All studies were conducted in the United
States, with the exception of one, which was located in Finland
(Montonen 2003). In seven ( Liu 2000; Liu 2003; Fung 2002;
Koh-Banerjee 2004; Salmeron 1997a; Salmeron 1997b; Schulze
2004) of the eleven studies participants were health professionals.
Exposure
Four studies assessed cereal fibre intake (Salmeron 1997a;
Salmeron1997b; Schulze2004; Stevens2002), three studieswhole
grain intake (Fung 2002; Liu 2003; van Dam 2006) and two
studies both whole grain and cereal fibre intake (Meyer 2000;
Montonen 2003). Two studiesmeasured the change inwhole grain
intake (Koh-Banerjee 2004; Liu 2003) and one of them also the
change in cereal fibre intake (Koh-Banerjee 2004).
Whole grain food was defined in most studies (Fung 2002; Liu
2000; Liu 2003; Meyer 2000) according to Jacobs et al (Jacobs
1998) and Liu et al (Liu 1999) and included dark bread, popcorn,
cooked oatmeal, wheat germ, brown rice, bran and other grains
(e.g. bulgar, kasha, couscous). Whole-grain breakfast cereals were
classified as whole grain as they contained more than 25% whole
grain or bran. Montonen et al (Montonen 2003) modified this
classification and did not include wheat germ and bran. Reported
amounts of food were converted to grams per day in their study.
Koh-Banerjee et al (Koh-Banerjee 2004) used in addition to the
previous described classification the definition issued by the FDA
for products eligible for a whole-grain health claim: foods that
contain more than 51% of whole grain (all portions of the kernel)
per reference amount customarily consumed (FDA 2005). Van
Dam et al (van Dam 2006) assessed the intake of whole grains
in form of “dark breads, such as wheat, rye, pumpernickel” and
“high fibre, bran or granola cereals, shredded wheat”.
Outcome measures
Nine studies measured the incidence of type 2 diabetes (Fung
2002; Liu 2000; Meyer 2000; Montonen 2003; Salmeron 1997a;
Salmeron 1997b; Schulze 2004; Stevens 2002; van Dam 2006)
and two studies changes in weight gain (Koh-Banerjee 2004; Liu
2003). One study reported the incidence of obesity (BMI more
than 30 kg/m2) and severe weight gain (more than 25 kg) (Liu
2003). The effect sizes for dichotomous data were expressed in
terms of relative risks (RR) in most studies, odds ratios (OR) in
one study (Liu 2003) or hazard ratios (HR) (Stevens 2002; van
Dam2006) in two studies. RRs andHRs reported are comparisons
between the upper category of intake (highest quartile/quintile)
and the lowest category (lowest quartile/quintile). The methods
used to determine RRs and HRs are listed in (see under Appendix
4. Qality assessment of cohort studies“ as well as the initial and ad-
justed effect sizes. In the publications no information of goodness
of fit of the statistical models were given. In all but two studies out-
come was assessed with a biennial questionnaire which was mailed
to all participants. Stevens et al (Stevens 2002) assessed incidence
of diabetes every three years andMontonen et al (Montonen 2003)
gained information about new type 2 diabetes cases needing drug
therapy via a central register of all patients receiving drug reim-
bursement.
None of the studies reported insulin sensitivity or glucose intoler-
ance.
Original purpose
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The original purpose of most studies was to investigate how diet
and other lifestyle factors influence the development of various
diseases. The primary aim of the Black Women’s Health study
(van Dam 2006) was to identify risk factors for diseases with high
prevalence in black women. The ARIC study (Stevens 2002) was
designed to investigate the aetiology of atherosclerosis and varia-
tion in cardiovascular risk factors, medical care and disease by race,
gender, location and date.
Excluded studies
Eleven studies were excluded. The main reason of exclusion was
that the diet administered during the intervention did not fulfil the
inclusion criteria (for details see under Characteristics of excluded
studies).
Risk of bias in included studies
Randomised controlled trials
The included trial (Pereira 2002) was a six-week intervention study
in 12 persons with a cross-over design and a washout period of six
to nine weeks.
Minimisation of selection bias
In the publication the trial was described as randomised but no
information about the randomisation procedure was given. Also,
no attempt to allocation concealment was described.
Minimisation of attrition bias
Data of three persons (25%) could not be used for the outcome
insulin sensitivity. One person became ill during the wash-out
period and did not complete the study. In two persons the clamp
tests were not completed due to technical difficulties.
Minimisation of detection bias
According to the protocol blinding of participants and people
administering the food was not rated as this concerns a dietary
intervention in which blinding is not possible. Blinding of the
outcome assessor was not reported in the publication.
Based on these quality criteria there is a high risk of bias in this
trial (category C).
Cohort studies
Number of appropriate confounders investigated and
adjusted for
The number of confounders that were used to correct the re-
sults varied considerably between the studies included (see under
Appendix 4). Thirty six percent of the studies did not adjust for
confounders that should have been minimally considered, namely
BMI, physical activity and family history of diabetes. Three stud-
ies (Meyer 2000; Montonen 2003; Stevens 2002) did not correct
for family history of diabetes and one study did not account for
physical activity (Montonen 2003). Confounders were assessed
with a self-administered questionnaire. Five studies (Meyer 2000;
Montonen 2003; Salmeron 1997a; Salmeron 1997b; van Dam
2006) did not repeat the assessment done at baseline, three stud-
ies (Fung 2002; Koh-Banerjee 2004; Schulze 2004) repeated the
assessment every two years and one study (Liu 2003) once after
two years and twice after four years. From two publications (Liu
2000; Stevens 2002) it became not clear whether assessment of
confounders was repeated.
Same method of measurement of outcome in exposed and
unexposed group
In all studies in all participants the same method of outcome mea-
surement was used regardless of the level of whole grain or cereal
fibre intake.
Quality of method used to assess outcome measures: self
report without validation, self report with validation, direct
measurement/medical records
In nine studies the outcome was self-reported. In one study it was
directly measured (serum glucose concentrations) (Stevens 2002)
and in one study (Montonen 2003) a central register of patients
receiving drug reimbursement was used. All studies using self-re-
ported diagnosis of type 2 diabetes validated the outcome in sub-
groups by comparing it with medical records. Studies with weight
gain as an outcome measure validated the self-reported weight in
subgroups by measuring weight directly (Koh-Banerjee 2004; Liu
2003). The validation studies showed over all a high agreement
between self report and control assessment (see Appendix 4). The
number of participants in the validation studies lay between 59
and 184. No information was given on what ground the subgroup
size was chosen.
Quality of method used to assess whole-grain intake
Dietary intake over the previous year was assessed with mailed
semi-quantitative food frequency questionnaires (FFQ) in nine
studies, in one study (Stevens 2002) it was interviewer adminis-
tered and in one study (Montonen 2003) a dietary history inter-
view was taken. The FFQ mostly assessed the intake of 100 to
134 items, two studies assessed intake of less than 100 items (68
items (van Dam 2006); 66 items (Stevens 2002)). Dietary assess-
ment was repeated one to three times in five studies (Fung 2002;
Koh-Banerjee 2004; Liu 2000; Liu 2003; Schulze 2004); the other
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studies did not repeat the assessment. In all studies results of the
dietary assessment were validated against results of detailed diet
records in subgroups. In two studies (Schulze 2004; Stevens 2002)
an FFQ was used that was not validated in a subgroup of the same
population. Examples of relevant correlation coefficients are listed
in Appendix 4’ and showed variable agreement. The number of
participants in the validation studies lay between 44 and 1844.
No information was given on what ground the subgroup size was
chosen.
Duration and completeness of follow-up
The duration of the studies lay between six and twelve years and
was considered to be long enough. Loss to follow-up (from sample
to study population) was only described in one study. Stevens et al
(Stevens 2002) reported an initial response rate of 67% in whites
and of 42% in African-American. Four studies reported response
rates to the repeated assessments of outcome. More than 80%
responded to biennial questionnaires send to the study population
in the study of van Dam et al (van Dam 2006) and 94% in that of
Fung et al. (Fung 2002). The response rate to the questionnaires
in the study ofMeyer et al (Meyer 2000) declined during the study
period (91%, 86%, 79%). Stevens et al (Stevens 2002) reported
that a total of approximately 80% of the study population that
remained alive at the end of the study period was examined at all
four visits.
Interrater agreement
The interrater agreement for study quality was measured using the
kappa statistic (Cohen 1960) and was 0.88. Differences between




Results of insulin sensitivity measurements of both intervention
periods were retrieved from the author (Pereira 2002) as only the
mean difference was given in the publication. Insulin sensitivity
(M-value) was measured with the euglycemic hyperinsulinemic
clamp test and was significantly higher after the feeding period
with whole grain (0.396 x 10−4 ± 0.131 x 10−4 mmol . kg−1. min
−1 per pmol/L) than after that with refined grain (0.323 x 10−4 ±
0.043 x 10−4 mol . kg−1. min −1 per pmol/L) (mean difference:
0.07 x 10−4 mmol . kg −1. min−1 per pmol/L, 95%CI 0.003 x 10
−4 to 0.144 x 10−4; P < 0.05). To examine violation of the cross-
over design assumption, the period by treatment interaction was
assessed in statistical models and not found to be significant. In
all the final models the main effect of period was included.
Secondary outcome measures
Adverse effects
Gastrointestinal symptoms recorded (heartburn, indigestion, di-
arrhoea, loose stools) were not significantly different between di-
ets. Frequency of bowel movements significantly increased with
the whole-grain diet (2 ± 0.2 versus 1 ± 0.2 movements/d; P <
0.001).
Patient satisfaction
Patient satisfaction was not included as an outcome.
Health-related quality of life
Health-related quality of life was not included as an outcome.
Total mortality
Total mortality was not included as an outcome.
Morbidity
Morbidity was not included as an outcome.
Costs
Costs were not included as an outcome.
Confounders
Compliance was controlled by comparing the energy content of
supplied food not eaten and food that was extra eaten (not sup-
plied).
The energy content of food not eaten during the intervention
periods did not differ significantly between the whole-grain (159
± 75 kJ/d) and the refined-grain (222 ± 126 kJ/d) diets. Also, the
energy content of extra food intake was not different (46 ± 25 kJ/
d whole-grain diet; 63 ± 33 kJ/d refined-grain diet).
Cohort studies
Data of studies were not pooled because of methodological diver-
sity (measures of effect size, statistical analyses used, number of
collected confounders).
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Whole grain intake and incidence of type 2 diabetes
Intake of whole grain was inversely associated with risk of type
2 diabetes in all five studies (comparison 01.01) which, however,
was not statistically significant in one study (Montonen 2003).
The discrepancy of this result with that of the other studies could
be caused by the relatively low number of participants (4.316) in
this study compared to mostly far more than 10.000 participants
in the other studies, which is also reflected by the width of the
confidential interval (0.67, 95% confidence interval (CI) 0.32 to
1.38).
The relative risks (RR) varied between 0.67 (95%CI 0.32 to 1.38)
and 0.79 (95%CI 0.65 to 0.96). After exclusion of studies that did
not correct for family history of diabetes (Meyer 2000; Montonen
2003) and physical activity (Montonen 2003), the observed effect
was very similar in the rest of the studies (RR of 0.70, 0.73 and
0.73).
Cereal fibre intake and incidence of type 2 diabetes
Intake of cereal fibre was inversely associated with type 2 diabetes
in all six studies (comparison 01.02). The RR varied between 0.37
(95%CI 0.20 to 0.77) and 0.79 (95%CI 0.67 to 0.93). Exclusion
of studies that did not correct for family history of diabetes (
Meyer 2000;Montonen 2003; Stevens 2002) and physical activity
(Montonen 2003) narrowed the range of the effect; the RR lay
between 0.63 and 0.72.
Stevens et al (Stevens 2002) also compared the hazard ratios of
diabetes in two subpopulations: cereal fibre intake was inversely
associated with risk of diabetes in whites and African-Americans
(0.86,95%CI0.65 to 1.15) but statistically different only inwhites
(0.75, 95% CI 0.60 to 0.92).
Change in whole grain intake and change in weight gain
The results of the studies investigating the association between
change in whole grain or cereal fibre intake and change in weight
gain are shown in Appendix 5. Over a time period of eight years
weight gain was reduced by 0.5 kg or 0.3 kg in the groups that
increasedwhole grain intake themost (dependent on the definition
of whole grain) in one study in men (Koh-Banerjee 2004) and by
0.4 kg over a period of 12 years in another study in women (Liu
2003). Similar results were observed when change in cereal fibre
intake was considered (0.4 kg less weight gain in eight years) (Koh-
Banerjee 2004). The odds of developing obesity (0.81, 95%CI
0.73 to 0.91) or having a major weight gain (0.77, 95% CI 0.59
to 1.01) tended to be lower with increased intake of whole grain
foods, as reported in the study of Liu et al (Liu 2003).
Assessment of publication bias
Publication bias was not assessed as it was considered to be not
useful due to the low number of studies (Lau 2006).
D I S C U S S I O N
Summary of main results
This review identified 12 studies examining the relation between
whole grain intake and the development of type 2 diabetes. Only
one study was a randomised controlled trial, the other 11 prospec-
tive cohort studies. The RCT had a cross-over design and showed
slight improvement of insulin sensitivity in obese hyperinsuli-
naemic participants after the whole grain intervention of six weeks.
However, the risk of bias in this study is considered to be high
since allocation concealment was not stated and the randomisa-
tion procedure was not described. The trial was of short duration
(minimum time period needed for inclusion) with a small sample
size. Whether the small elevation of the insulin sensitivity has any
clinical relevance is doubtful. However, from a theoretical perspec-
tive it could add to the delay of the onset of type 2 diabetes.
The results of the cohort studies were homogenous. None of the
studies showed the opposite effect; in one study the effect was not
significant. Significantly decreased risk of development of type 2
diabeteswas associated in four cohort studieswith highwhole grain
intake (range: 21% to 30%) and in six studies with high cereal
fibre intake, (range: 21% to 63%) which can be considered to be a
marker of whole grain consumption. Two studies investigated the
effect of whole grain consumption on overweight, an important
risk factor for type 2 diabetes. Increased whole grain consumption
was associated with only a very slight reduction (0.3 to 0.5 kg)
in weight gain and a reduced risk of becoming obese during the
follow-up period. The slight reductions in weight gain can not
be regarded as clinical relevant considering the long time periods
(eight and twelve years) in which they were observed.
The methodological quality varied between studies mainly with
regard to the food intake assessment and the numbers of con-
founders considered. Food intake was inmost studies assessed with
food frequency questionnaires. One limitation of this approach is
the small number of food items listed (66 to 134 items) which re-
stricts extensive assessment of the food products of interest. None
of the food frequency questionnaires was designed especially for
assessment of whole grain foods.Measurement error of food intake
due to inter-individual variation during the course of the years can
be reduced by repeated collection of dietary information. Only
five studies repeated the measurement to obtain a better reflec-
tion of the long-term intake. Measurement errors in dietary intake
may thus have limited the ability to obtain accurate risk estimates.
Residual confounding is a problem in prospective cohort studies.
As observed in these studies, higher intake of whole grain food
tends to be associated with healthier lifestyle and incomplete ad-
justment of lifestyle factors may result in an overestimation of the
effect.
12Whole grain foods for the prevention of type 2 diabetes mellitus (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Potential biases in the review process
The main limitation of this review is that evidence of a possible
protective effect of a diet rich in whole grain foods on the de-
velopment of type 2 diabetes is retrieved only from prospective
cohort studies of which some were of limited quality. As prospec-
tive cohort studies are more prone to bias and confounding than
randomised controlled trials results have to be interpreted with
caution.
Generalisability and applicability of results
All but one study were conducted in the United States. Most
American studies were done in health care workers but the results
of three different populations (Iowa women Health study (Meyer
2000), Atherosclerosis Risk in Communities study (Stevens 2002)
andU.S. blackwomen study (van Dam 2006)) were comparable as
were those of the study conducted in Finland (Montonen 2003).
As the majority of studies was conducted in only one part of the
world generalisability of results is uncertain.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The evidence from the prospective cohort trials is considered to
be too weak to be able to draw a definite conclusion about the
preventive effect of whole grain foods on the development of type
2 diabetes.
Implications for research
Properly designed long-term randomised controlled trials are
needed to establish whether whole grain foods are protective for
the development of type 2diabetes. To facilitate this, furthermech-
anistic research should focus on finding a set of relevant inter-
mediate endpoints for type 2 diabetes and on identifying genetic
subgroups of the population at risk that are most susceptible to
dietary intervention.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bakker 1998 Only intake of total dietary fiber and not of cereal fiber was measured
Feskens 1991 Only carbohydrate intake was measured and not whole-grain intake
Hodge 1996 Only intake of total dietary fiber and not of cereal fiber was measured
Juntunen 2003 The test meals did not fulfill our inclusion criteria.
Liese 2003 This was a cross-sectional study.
Marshall 1993 Only intake of total dietary fiber and not of cereal fiber was measured
Sloth 2004 Both dietary interventions consisted of whole-grain foods.
Vinceti 1994 Intake of whole-grain or cereal fiber was not measured.
Weickert 2006 The test meals did not fulfill our inclusion criteria.
Wolever 2002 The dietary intervention did not fulfill our inclusion criteria
Wolever 2003 The dietary intervention did not fulfill our inclusion criteria
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D A T A A N D A N A L Y S E S
Comparison 1. incidence of type 2 diabetes




participants Statistical method Effect size
1 Low versus high intake of whole
grain
5 RR or HR (Random, 95% CI) Totals not selected
2 Low versus high intake of cereal
fiber
6 RR or HR (Random, 95% CI) Totals not selected
Analysis 1.1. Comparison 1 incidence of type 2 diabetes, Outcome 1 Low versus high intake of whole grain.
Review: Whole grain foods for the prevention of type 2 diabetes mellitus
Comparison: 1 incidence of type 2 diabetes
Outcome: 1 Low versus high intake of whole grain
Study or subgroup log [RR or HR] RR or HR RR or HR
(SE) IV,Random,95% CI IV,Random,95% CI
Liu 2000 -0.3147 (0.0776) 0.73 [ 0.63, 0.85 ]
Meyer 2000 -0.2357 (0.0994) 0.79 [ 0.65, 0.96 ]
Fung 2002 -0.3567 (0.0991) 0.70 [ 0.58, 0.85 ]
Montonen 2003 -0.4005 (0.3687) 0.67 [ 0.33, 1.38 ]
van Dam 2006 -0.3147 (0.0776) 0.73 [ 0.63, 0.85 ]
0.2 0.5 1 2 5
Favours high intake Favours low intake
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Analysis 1.2. Comparison 1 incidence of type 2 diabetes, Outcome 2 Low versus high intake of cereal fiber.
Review: Whole grain foods for the prevention of type 2 diabetes mellitus
Comparison: 1 incidence of type 2 diabetes
Outcome: 2 Low versus high intake of cereal fiber
Study or subgroup log [RR or HR] RR or HR RR or HR
(SE) IV,Random,95% CI IV,Random,95% CI
Salmeron 1997a -0.3285 (0.1138) 0.72 [ 0.58, 0.90 ]
Salmeron 1997b -0.3567 (0.1611) 0.70 [ 0.51, 0.96 ]
Meyer 2000 -0.4463 (0.1074) 0.64 [ 0.52, 0.79 ]
Stevens 2002 -0.2357 (0.0832) 0.79 [ 0.67, 0.93 ]
Montonen 2003 -0.9934 (0.406) 0.37 [ 0.17, 0.82 ]
Schulze 2004 -0.462 (0.1528) 0.63 [ 0.47, 0.85 ]
0.2 0.5 1 2 5
Favours high intake Favours low intake
A P P E N D I C E S
Appendix 1. Search strategy
Search terms
Unless otherwise stated, search terms are free text terms; MeSH = Medical subject heading (Medline medical index term); exp =
exploded MeSH; the dollar sign ($) stands for any character(s); the question mark (?) = to substitute for one or no characters; tw =








8. exp Dietary fibre/
9. dietary fibre$.tw.
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(Continued)
10. dietary fibre$.tw.
11. exp Dietary Carbohydrates/
12. exp Glycemic index/
13. dietary carbohydrate$.tw.
14. (glyc?emic ind$ or GI).tw.
15. or/1-14
16. exp Insulin Resistance/





22. exp Diabetes Mellitus, Type 2
23. exp Metabolic Syndrome X/
24. or /16-23
25. 15 and 24
Appendix 2. Characteristics: randomized controlled trial
Study ID Methods Participants Interventions Outcomes Allocation conc.
Pereira 2002 Cross-over
nonblinded RCT;
2 feeding periods of
6weeks, wash-out pe-
riod of 6 - 9 weeks;
randomisation done
but method unclear
6men, 6 women; age:
21 - 65 y
exclusion criteria:
- Body Mass Index >
26 and < 36
- Body weight fluctu-
ation over the past 6
mo of > 10 %
- Smoking cigarettes








that would affect glu-




grain foods at break-
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(Continued)
- Engaging in a high
level of physical activ-
ity
- Following a special
diet
- Allergic to any
foods





out of town or take a
lengthy vacation dur-
ing the time of the
study
- Fasting blood glu-
cose > 6.0 mmol/L




Appendix 3. Characteristics: cohort studies
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(Continued)
unclear the past 6
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55 - 69 y 127-item
FFQ





















40 - 75 y 131-item
FFQ






















T2 DM 156 Cereal
fibre:
1 - 12 g/d
Whole
grain:
0 - 109 g/d
Cereal
fibre:
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24 - 44 y 133-item
FFQ

























































































































21 - 69 y 68-item
FFQ
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Appendix 4. Quality assessment: of cohort studies
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no yes 4-8 mo, n
= 93 total
grain: 0.62,
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no yes n = 408
fibre 0.57
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Appendix 5. Results of studies assessing change and gain in weight
Study Measurement Lowest quintile Highest quintile P for trend




Change in weight (kg)
(mean +/- SE)
1.3 +/- 0.2 0.7 +/- 0.2 < 0.0001
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(Continued)
Change in weight (kg)
(mean +/- SE)
1.0 +/- 0.2 0.7+/- 0.2 0.002
Koh-Banerjee 2003 Median change in cereal
fibre intake (g/d)
- 2 5
Change in weight (kg)
(mean +/- SE)
1.1 +/- 0.2 0.8 +/- 0.2 0.0002




Change in weight (kg)
(mean SE)
4.5 +/- 0.1 4.1 +/- 0.1 < 0.0001
Liu 2004 Odds ratio for BMI > 29.
9
(n = 6 400)
1 0.81 (95% CI 0.73 to 0.91) 0.0002
Liu 2004 Odds ratio forweight gain
> 24.9 kg
(n = 657)
1 0.77 (95% CI 0.59 to 1.01) 0.03
WH A T ’ S N E W
Date Event Description
1 November 2008 Amended Converted to new review format.
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